Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
The American Journal of Medicine
|
June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
J C Wade, H C Standiford, G L Drusano, et al.
The American Journal of Medicine
|
July 20, 1982
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
J D Meyers, J C Wade, C D Mitchell, et al.
Infection
|
September 1, 1983
Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures
C D Buckner, R A Clift, E D Thomas, et al.
The Journal of Infectious Diseases
|
March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
W T Hughes, D Armstrong, G P Bodey, et al.
Hormone Research
|
January 1, 1996
Biochemical markers of bone turnover
P M Crofton, H F Stirling, E Schönau, et al.
Clinical Endocrinology
|
August 31, 2002
Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnover
C P Doherty, P M Crofton, M A K Sarkar, et al.
The New England Journal of Medicine
|
June 16, 1983
Acyclovir halts progression of herpes zoster in immunocompromised patients
H H Balfour, B Bean, O L Laskin, et al.
The American Journal of Medicine
|
July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin
C A De Jongh, J C Wade, S C Schimpff, et al.
Health Management Technology
|
June 6, 1997
Enterprise integration. The CIO tapes. Roundtable discussion
M Anderson, L Bates, R D Brickman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
H Ozer, J O Armitage, C L Bennett, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
The American Journal of Medicine
|
June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
J C Wade, H C Standiford, G L Drusano, et al.
The American Journal of Medicine
|
July 20, 1982
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
J D Meyers, J C Wade, C D Mitchell, et al.
Infection
|
September 1, 1983
Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures
C D Buckner, R A Clift, E D Thomas, et al.
The Journal of Infectious Diseases
|
March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
W T Hughes, D Armstrong, G P Bodey, et al.
Hormone Research
|
January 1, 1996
Biochemical markers of bone turnover
P M Crofton, H F Stirling, E Schönau, et al.
Clinical Endocrinology
|
August 31, 2002
Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnover
C P Doherty, P M Crofton, M A K Sarkar, et al.
The New England Journal of Medicine
|
June 16, 1983
Acyclovir halts progression of herpes zoster in immunocompromised patients
H H Balfour, B Bean, O L Laskin, et al.
The American Journal of Medicine
|
July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin
C A De Jongh, J C Wade, S C Schimpff, et al.
Health Management Technology
|
June 6, 1997
Enterprise integration. The CIO tapes. Roundtable discussion
M Anderson, L Bates, R D Brickman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
H Ozer, J O Armitage, C L Bennett, et al.
Page
of 8